Home » Sponsors Could Skirt Trial Requirements Under Senator’s ‘Progressive Approval’
Sponsors Could Skirt Trial Requirements Under Senator’s ‘Progressive Approval’
Draft proposals from Sen. Kay Hagan (D-N.C.) and the Biotechnology Industry Organization (BIO) would allow the FDA to grant marketing authorizations before sponsors meet current clinical trial requirements.
Clinical Trials Advisor
Clinical Trials Advisor
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May